Reported Decision:
(2006) 14 ANZ Insurance Cases 61-700
New South Wales
Supreme Court
CITATION: Cat Media Pty Ltd v Allianz Australia Insurance Ltd [2006] NSWSC 423 HEARING DATE(S): 27, 28, 29 March 2006, 3, 4 April 2006, 12, 24 May 2006
JUDGMENT DATE :
24 May 2006JUDGMENT OF: Bergin J DECISION: Second Further Amended Summons dismissed. CATCHWORDS: [INSURANCE] — Plaintiff insured with defendant for business interruption consequent upon “closure” of manufacturer’s premises — Manufacturer’s licence to manufacture plaintiff’s product suspended — Whether consequences of suspension of licence amounted to “closure” of manufacturer’s premises. LEGISLATION CITED: Food Standards Australia New Zealand Act 1991 (Cth)
Law Enforcement (Powers and Responsibilities) Act 2002 (NSW)
Public Health Act 1999 (NSW)
Therapeutic Goods Act 1989 (Cth)CASES CITED: Re Anti-Cancer Council of Victoria; Ex Parte State Public Services Federation (1992) 175 CLR 442
Federal Commissioner of Taxation v Silverton Tramway Company Ltd (1953) 88 CLR 559
McCann v Switzerland Insurance Australia Ltd (2000) 203 CLR 579
R v Clarke [1969] 2 QB 91
Renmark Hotel Inc v Federal Commissioner of Taxation (1949) 79 CLR 10
Western Australian Turf Club v Federal Commissioner of Taxation (1978) 139 CLR 288
Wilkie v Gordian Runoff Ltd (2005) 79 ALJR 872PARTIES: Cat Media Pty Limited (ACN 077 817 522) (plaintiff)
Allianz Australia Insurance Limited (ACN 000 122 850) (defendant)FILE NUMBER(S): SC 50064/04 COUNSEL: JB Simpkins SC/JAC Potts (plaintiff)
AS Martin SC/SA Wells (defendant)SOLICITORS: Clayton Utz (plaintiff)
McMahons National Lawyers (defendant)
IN THE SUPREME COURT
OF NEW SOUTH WALES
EQUITY DIVISION
COMMERCIAL LIST
BERGIN J
24 MAY 2006
50064/04 CAT MEDIA PTY LIMITED v ALLIANZ AUSTRALIA INSURANCE LIMITED
JUDGMENT
- Background
1 On 28 April 2003 the licence of Pan Pharmaceuticals Limited (Pan) to manufacture non-sterile therapeutic goods for human use (the Licence) was suspended for a period of 6 months pursuant to s 41 of the Therapeutics Goods Act 1989 (Cth) (the Act) by notice signed by the Delegate of the Secretary of the Department of Health and Ageing (the Notice). The Notice advised that Pan (and/or a related entity) had breached conditions of the Licence and had failed to observe “Manufacturing Principles” (the Principles).
2 The Principles, determined from time to time by the Minister, are written principles to be observed in the manufacture of therapeutic goods for use in humans (s 36(1) of the Act). They relate, inter alia, to standards to be maintained and equipment to be used (s 36(2)(a)), procedures for quality assurance and control (s 36(2)(b)), manufacturing practices (s 36(2)(d)), and other matters relevant to the quality, safety and efficacy of therapeutic goods for use in humans that are manufactured in Australia (s 36(2)(e)). “Therapeutic goods” include goods that are, or are likely to be taken to be, for therapeutic use (s 3). “Therapeutic use” means “use in, or in connection with, (a) preventing, diagnosing, curing or alleviating a disease, ailment, defect or injury in persons or animals; or (b) influencing, inhibiting or modifying a physiological process…
Keep reading for free
Create a free CaseChat account to read Cat Media Pty Ltd v Allianz Australia Insurance Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2006] NSWSC 423
- Decision Date
CaseChat Overview and Summary
The primary legal issue before the court was whether the suspension of the manufacturer's licence, which effectively halted production at the premises, amounted to a "closure" of the premises within the meaning of the insurance policy. This required the court to interpret the term "closure" and determine if it included situations where a licence necessary for operations was suspended. The court needed to balance the plain meaning of the term against the context and purpose of the insurance policy, as well as any relevant legislative framework governing the suspension of manufacturing licences.
The court held that the suspension of the manufacturer's licence did not amount to a "closure" of the premises as defined in the insurance policy. The term "closure" was interpreted to mean a physical or legal cessation of operations that would render the premises unusable, rather than a temporary suspension of operations due to regulatory issues. The court found that the policy's purpose was to cover permanent, not temporary, cessations of business. Consequently, the insurer's denial of the claim was upheld, and Cat Media's appeal was dismissed.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi